SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,795.00    100.00 (1.49%)
Bid:
6,790.00
Ask:
6,800.00
Spread: 10.00 (0.147%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

20 May 2014 07:00

RNS Number : 5236H
Spirax-Sarco Engineering PLC
20 May 2014
Β 

ο»Ώ

Β 

Β 

News Release

Β 

Tuesday 20th May 2014

INTERIM MANAGEMENT STATEMENT

Β 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st January 2014 to 19th May 2014, ahead of its Annual General Meeting ("AGM") today at 2.00pm.

Β 

Trading

Global economic conditions have shown little change of direction in the period since our last outlook statement in early March. 2014 has started in line with our expectations, which remain unchanged for the full year.

Β 

For the four months ended 30th April 2014, organic sales increased by nearly 4% and acquisitions added nearly 1%. Currency headwinds reduced sales on translation, leaving reported sales marginally lower than the prior year. Sales growth was strongest in the Americas, with increases in both North and Latin America. Watson-Marlow also started well, including a contribution from Bio Pure that has made an excellent start, and modest growth continued in our steam specialties business in Europe, Middle East and Africa ("EMEA"). In Asia Pacific, we built a larger project-based backlog than in the comparable period, leading to flat organic sales and supportive of relatively stronger second half sales in that region.

Β 

Group operating profit was ahead of the comparable period in 2013 both on a constant currency and on a reported basis, largely reflecting the contribution from higher sales and relatively flat material input costs.

Β 

Financial position

The Group remains highly cash generative and maintains a strong balance sheet, with the net cash balance increasing from Β£16 million at 31st December 2013 to Β£25 million at 30th April 2014, despite the Β£8m outflow in respect of the acquisition of Bio Pure in January, the adverse impact of currency movements on translation and the usual seasonal cash outflow pattern. If approved at the AGM, the final dividend of 41p per share in respect of 2013, totalling Β£31 million, will be paid on 30th May 2014. There has been no material change in the financial position of the Group during the period and the principal risks and uncertainties remain as set out on pages 26 and 27 of the 2013 Annual Report.

Β 

Outlook

We continue to assume that our markets will exhibit low levels of growth, in line with modest overall improvement in Industrial Production growth through the course of 2014. Although strong currency headwinds persist, we remain focused on our strategic priorities to create our own growth, which, together with our fundamental strengths, gives the Board confidence that the Group will make further progress in 2014.

Β 

Spirax Sarco will publish its half-year results on 7th August 2014.

Β 

Β 

Enquiries:

Nick Anderson, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

Β 

Β 

Β 

Β 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.comΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBRGDUDSBBGSC
Date   Source Headline
21st Nov 20173:08 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTrading Statement
14th Nov 201710:39 amRNSDirector/PDMR Shareholding
16th Oct 20175:35 pmRNSDirector/PDMR Shareholding
29th Sep 20173:36 pmRNSHolding(s) in Company
9th Aug 20177:00 amRNSHalf-year Report
4th Jul 20177:00 amRNSCompletion of Acquisition
23rd Jun 20179:11 amRNSTotal Voting Rights
20th Jun 20173:59 pmRNSHolding(s) in Company
12th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20179:08 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSAcquisition of Chromalox for US$415 million
9th May 20174:30 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
4th May 20174:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Acquisition
26th Apr 20178:42 amRNSHolding(s) in Company
25th Apr 20179:10 amRNSHolding(s) in Company
19th Apr 20173:55 pmRNSHolding(s) in Company
18th Apr 20173:58 pmRNSHolding(s) in Company
3rd Apr 20177:30 amRNSAcquisition
24th Mar 20174:44 pmRNSTotal Voting Rights
23rd Mar 20171:45 pmRNSDirector/PDMR Shareholding
17th Mar 20174:04 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
30th Nov 20167:00 amRNSAcquisition
22nd Nov 20167:00 amRNSTrading Statement
17th Nov 20164:23 pmRNSDirector/PDMR Shareholding
14th Nov 20168:30 amRNSDr Krishnamurthy Rajagopal
10th Nov 201611:40 amRNSListing Application
8th Nov 201611:57 amRNSChange of Director Details
4th Nov 20164:27 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSBoard Succession Changes
17th Oct 20162:49 pmRNSAdditional Listing
14th Oct 20165:03 pmRNSDirector/PDMR Shareholding
14th Oct 20163:20 pmRNSTotal Voting Rights
14th Oct 20163:17 pmRNSBlock listing Interim Review
6th Oct 201611:48 amRNSNotification of Release Date - Trading Statement
8th Sep 201612:44 pmRNSTotal Voting Rights
18th Aug 20168:30 amRNSBoard Appointment
12th Aug 20163:51 pmRNSDirector/PDMR Shareholding
9th Aug 20167:05 amRNSSpirax Sarco acquires assets of Hiter for £3.9 m
9th Aug 20167:00 amRNS2016 Half Year Results
5th Aug 20162:56 pmRNSTotal Voting Rights
1st Jul 201611:43 amRNSTotal Voting Rights
29th Jun 20169:29 amRNSNotice of Results
21st Jun 20165:40 pmRNSDirector/PDMR Shareholding
10th Jun 20162:59 pmRNSHolding(s) in Company
2nd Jun 20164:20 pmRNSAdditional Listing
2nd Jun 20163:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.